Axsome Therapeutics Inc AXSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
76.54UNCH (UNCH)
Volume
13,439
Close
76.54quote price arrow down-0.81 (-1.05%)
Volume
471,174
52 week range
55.02 - 98.40
Loading...
  • Open77.48
  • Day High78.09
  • Day Low75.63
  • Prev Close77.35
  • 52 Week High98.40
  • 52 Week High Date02/12/24
  • 52 Week Low55.02
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap3.635B
  • Shares Out47.50M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-3.83

KEY STATS

  • Open77.48
  • Day High78.09
  • Day Low75.63
  • Prev Close77.35
  • 52 Week High98.40
  • 52 Week High Date02/12/24
  • 52 Week Low55.02
  • 52 Week Low Date11/13/23
  • Market Cap3.635B
  • Shares Out47.50M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-3.83

RATIOS/PROFITABILITY

  • EPS (TTM)-6.38
  • P/E (TTM)-11.99
  • Fwd P/E (NTM)-17.05
  • EBITDA (TTM)-285.723M
  • ROE (TTM)-231.68%
  • Revenue (TTM)251.023M
  • Gross Margin (TTM)90.12%
  • Net Margin (TTM)-118.07%
  • Debt To Equity (MRQ)125.24%

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Axsome Therapeutics Inc

Profile

MORE
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive...
Herriot Tabuteau M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Lori Englebert
Executive Vice President - Commercial and Business Development
Hunter Murdock Esq.
General Counsel
Address
One World Trade Center, 22Nd Floor
New York, NY
10007
United States

Top Peers

SYMBOLLASTCHG%CHG
IMCR
Immunocore Holdings PLC
53.29-0.96-1.77%
INSM
Insmed Inc
24.77-0.33-1.31%
MOR
MorphoSys AG
19.00-0.34-1.76%
RARE
Ultragenyx Pharmaceutical Inc
41.87-0.74-1.74%
CRSP
CRISPR Therapeutics AG
56.22+0.55+0.99%